These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 28880970)

  • 41. Differential inhibition of murine Bcrp1/Abcg2 and human BCRP/ABCG2 by the mycotoxin fumitremorgin C.
    González-Lobato L; Real R; Prieto JG; Alvarez AI; Merino G
    Eur J Pharmacol; 2010 Oct; 644(1-3):41-8. PubMed ID: 20655304
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins.
    van Herwaarden AE; Schinkel AH
    Trends Pharmacol Sci; 2006 Jan; 27(1):10-6. PubMed ID: 16337280
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional expression of breast cancer resistance protein and cholesterol effect in human erythrocyte membranes.
    Takano M; Higashi M; Ito H; Toyota S; Hirabayashi Y; Yumoto R
    Pharmazie; 2018 Dec; 73(12):700-705. PubMed ID: 30522552
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Downregulation of breast cancer resistance protein in colon adenomas reduces cellular xenobiotic resistance and leads to accumulation of a food-derived carcinogen.
    Dietrich CG; Vehr AK; Martin IV; Gassler N; Rath T; Roeb E; Schmitt J; Trautwein C; Geier A
    Int J Cancer; 2011 Aug; 129(3):546-52. PubMed ID: 21544799
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigation of quinazolines as inhibitors of breast cancer resistance protein (ABCG2).
    Juvale K; Gallus J; Wiese M
    Bioorg Med Chem; 2013 Dec; 21(24):7858-73. PubMed ID: 24184213
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The ABC transporter Abcg2/Bcrp: role in hypoxia mediated survival.
    Krishnamurthy P; Schuetz JD
    Biometals; 2005 Aug; 18(4):349-58. PubMed ID: 16158227
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Breast cancer resistance protein (BCRP) in acute leukemia.
    Plasschaert SL; Van Der Kolk DM; De Bont ES; Vellenga E; Kamps WA; De Vries EG
    Leuk Lymphoma; 2004 Apr; 45(4):649-54. PubMed ID: 15160935
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 4-Anilino-2-pyridylquinazolines and -pyrimidines as Highly Potent and Nontoxic Inhibitors of Breast Cancer Resistance Protein (ABCG2).
    Krapf MK; Gallus J; Wiese M
    J Med Chem; 2017 May; 60(10):4474-4495. PubMed ID: 28471656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new intestinal cell culture model to discriminate the relative contribution of P-gp and BCRP on transport of substrates such as imatinib.
    Graber-Maier A; Gutmann H; Drewe J
    Mol Pharm; 2010 Oct; 7(5):1618-28. PubMed ID: 20701289
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of variations in the amounts of P-glycoprotein (ABCB1), BCRP (ABCG2) and CYP3A4 along the human small intestine on PBPK models for predicting intestinal first pass.
    Bruyère A; Declèves X; Bouzom F; Ball K; Marques C; Treton X; Pocard M; Valleur P; Bouhnik Y; Panis Y; Scherrmann JM; Mouly S
    Mol Pharm; 2010 Oct; 7(5):1596-607. PubMed ID: 20604570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.
    Assaraf YG
    Drug Resist Updat; 2006; 9(4-5):227-46. PubMed ID: 17092765
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Zafirlukast antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.
    Sun YL; Kathawala RJ; Singh S; Zheng K; Talele TT; Jiang WQ; Chen ZS
    Anticancer Drugs; 2012 Sep; 23(8):865-73. PubMed ID: 22614107
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dietary polyacetylenes of the falcarinol type are inhibitors of breast cancer resistance protein (BCRP/ABCG2).
    Tan KW; Killeen DP; Li Y; Paxton JW; Birch NP; Scheepens A
    Eur J Pharmacol; 2014 Jan; 723():346-52. PubMed ID: 24269959
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Residues contributing to drug transport by ABCG2 are localised to multiple drug-binding pockets.
    Cox MH; Kapoor P; Briggs DA; Kerr ID
    Biochem J; 2018 May; 475(9):1553-1567. PubMed ID: 29661915
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Membrane transport of dietary phenethyl isothiocyanate by ABCG2 (breast cancer resistance protein).
    Ji Y; Morris ME
    Mol Pharm; 2005; 2(5):414-9. PubMed ID: 16196494
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ixabepilone, a novel microtubule-targeting agent for breast cancer, is a substrate for P-glycoprotein (P-gp/MDR1/ABCB1) but not breast cancer resistance protein (BCRP/ABCG2).
    Shen H; Lee FY; Gan J
    J Pharmacol Exp Ther; 2011 May; 337(2):423-32. PubMed ID: 21262849
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fetoprotective activity of breast cancer resistance protein (BCRP, ABCG2): expression and function throughout pregnancy.
    Hahnova-Cygalova L; Ceckova M; Staud F
    Drug Metab Rev; 2011 Feb; 43(1):53-68. PubMed ID: 20854129
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of novel dietary phytochemicals inhibiting the efflux transporter breast cancer resistance protein (BCRP/ABCG2).
    Tan KW; Li Y; Paxton JW; Birch NP; Scheepens A
    Food Chem; 2013 Jun; 138(4):2267-74. PubMed ID: 23497885
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2.
    Mizuarai S; Aozasa N; Kotani H
    Int J Cancer; 2004 Mar; 109(2):238-46. PubMed ID: 14750175
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The product of the ABC half-transporter gene ABCG2 (BCRP/MXR/ABCP) is expressed in the plasma membrane.
    Rocchi E; Khodjakov A; Volk EL; Yang CH; Litman T; Bates SE; Schneider E
    Biochem Biophys Res Commun; 2000 Apr; 271(1):42-6. PubMed ID: 10777678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.